Emory University clinical trial pipeline
Data updated daily from ClinicalTrials.gov, last refresh 2026-11-19
What changed in the last 30 days
25 trials changed in the last 30 days: 2 stopped, 16 with notable changes, 7 with minor changes only.
- Notable: VOICE · Virtual Outreach and Individualized Coaching Extension Start date pushed from Oct 2026 to Dec 2026
- Notable: 6 Hour Oxaliplatin Infusions · Gastrointestinal Cancers Primary completion pushed from Aug 5, 2026 to Aug 5, 2027
- Notable: Pectoralis Minor Release Versus Non-release in RSA Primary and study completion pushed from Jan 2026 to Dec 2027
- Notable: APPROACH · Adaptango Performance PRocess for Older Adults Community reHabilitation Recruitment opened
- Minor: Opioid-Free Orthopaedics Trial completed
- Minor: Asthma Navigator Intervention to Improve Health Equity in Children Primary completion pushed from Aug 2026 to Feb 2027
- Notable: EMBRACE Study: Enflonsia Monoclonal in Babies - RSV Antibody Concentration Evaluation Start date pushed from Sep 2026 to Nov 2026
- Stopped: SAFE · Ty of aPCC Following Emicizumab Prophylaxis Trial status changed: Recruiting → Withdrawn
- Notable: Response to Emerging Antimicrobial Resistance With Containment Microbiota Therapy (REACT) Primary endpoint(s) modified
- Notable: Virtual Home-based Exercise Intervention (RISE) to Improve Cancer-Related Cognitive Impairment and Gut Microbiome in Adolescent and Young Adult Brain Tumor Survivors Primary completion pushed from Jul 31, 2026 to Jul 31, 2027
- Notable: CRCweb · Web-Based Dyadic Intervention for Colorectal Cancer Primary completion pushed from Oct 1, 2026 to Oct 1, 2027
- Notable: APPLES-TELE · Telemedicine in Early Childhood Constraint Therapy in Cerebral Palsy Primary endpoint(s) modified
- Notable: PET/CT Assessment of Radiation-Induced Vascular Complications in Head and Neck Cancer Primary completion pushed from Aug 31, 2026 to Aug 31, 2027
- Notable: Community, Home-based Education, Screening Services Strategy to Increase Cervical Cancer Control Access for HIV-Positive Women in Nigeria Primary and study completion pushed from Jun 2026 to Aug 2028
- Notable: US/PA/E Imaging for Early Identification of Tumor Response · Stage II-III Triple Negative Breast Cancer Receiving Neoadjuvant Immunotherapy and Chemotherapy Start date pushed from Oct 1, 2026 to Jan 1, 2027
- Notable: CT- Versus MRI-Based Planning for High-Dose-Rate Prostate Brachytherapy for Prostate Cancer Recruitment opened
- Minor: MIND-CKD · Mindfulness in Chronic Kidney Disease Trial completed
- Minor: REAL TTIME · Rural Expanded Access to OUD Care & Linkage Using Toxicologists for Telehealth Initiated Treatment Trial completed
- Stopped: Verteporfin · Recurrent High Grade EGFR-Mutated Glioblastoma Trial terminated
- Notable: Mental Stress Reactivity · CMD Primary and study completion dates pushed to Dec 2028
- Stopped: terminated, suspended or withdrawn
- Notable: the plan changed
- Minor: routine updates
New trial filings, last 30 days
| First posted | Trial | Phase | Status |
|---|---|---|---|
| 2026-11-16 | NCT07938567 Preeclampsia Screening Trial to Improve Outcomes | Not Yet Recruiting |
Active trials by phase
| Early Phase 1 | 7 | |
| Phase 1 | 24 | |
| Phase 1/2 | 3 | |
| Phase 2 | 61 | |
| Phase 3 | 6 | |
| Phase 4 | 18 |
Not charted: 148 active trials with no phase listed on ClinicalTrials.gov (typically behavioural, device, procedure and observational studies).
Disease areas by active trials, top 10 of 58
Diabetes (14) · Depression (11) · Heart Disease (11) · Prostate Cancer (11) · PTSD (10) · Breast Cancer (9) · Head & Neck Cancer (9) · Dementia (8) · Lung Cancer (8) · Colorectal Cancer (7)
Get alerts when Emory University's trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.